Your browser doesn't support javascript.
loading
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
Bidard, F-C; Ng, C K Y; Cottu, P; Piscuoglio, S; Escalup, L; Sakr, R A; Reyal, F; Mariani, P; Lim, R; Wang, L; Norton, L; Servois, V; Sigal, B; Vincent-Salomon, A; Weigelt, B; Pierga, J-Y; Reis-Filho, J S.
Afiliación
  • Bidard FC; Department of Medical Oncology, Institut Curie, Paris, France Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA fcbidard@curie.fr.
  • Ng CK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Cottu P; Department of Medical Oncology, Institut Curie, Paris, France.
  • Piscuoglio S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Escalup L; Department of Pharmacy, Institut Curie, Paris, France.
  • Sakr RA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Reyal F; Department of Surgery, Institut Curie, Paris, France.
  • Mariani P; Department of Surgery, Institut Curie, Paris, France.
  • Lim R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Wang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Norton L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Servois V; Department of Radiology, Institut Curie, Paris.
  • Sigal B; Department of Pathology, Institut Curie, Paris.
  • Vincent-Salomon A; Department of Pathology, Institut Curie, Paris.
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Pierga JY; Department of Medical Oncology, Institut Curie, Paris, France Paris Descartes University, Paris, France.
  • Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA Department of Computational Biology, Memorial Sloan Kettering Cancer Center, New York, USA.
Ann Oncol ; 26(8): 1704-9, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25953157
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Receptor ErbB-3 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Receptor ErbB-3 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article